A truncating mutation in the autophagy gene UVRAG drives inflammation and tumorigenesis in mice.

Quach, Christine; Song, Ying; Guo, Hongrui; Li, Shun; Maazi, Hadi; Fung, Marshall; Sands, Nathaniel; O'Connell, Douglas et al. · Nat Commun · 2019

basic_science · Level V

Where this comes from

Abstract

Aberrant autophagy is a major risk factor for inflammatory diseases and cancer. However, the genetic basis and underlying mechanisms are less established. UVRAG is a tumor suppressor candidate involved in autophagy, which is truncated in cancers by a frameshift (FS) mutation and expressed as a shortened UVRAG<sup>FS</sup>. To investigate the role of UVRAG<sup>FS</sup> in vivo, we generated mutant mice that inducibly express UVRAG<sup>FS</sup> (iUVRAG<sup>FS</sup>). These mice are normal in basal autophagy but deficient in starvation- and LPS-induced autophagy by disruption of the UVRAG-autophagy complex. iUVRAG<sup>FS</sup> mice display increased inflammatory response in sepsis, intestinal colitis, and colitis-associated cancer development through NLRP3-inflammasome hyperactivation. Moreover, iUVRAG<sup>FS</sup> mice show enhanced spontaneous tumorigenesis related to age-related autophagy suppression, resultant β-catenin stabilization, and centrosome amplification. Thus, UVRAG is a crucial autophagy regulator in vivo, and autophagy promotion may help prevent/treat inflammatory disease and cancer in susceptible individuals.

Medical subject headings